Close

Mylan (MYL) Gains on Generic Concerta Approval

October 25, 2016 11:46 AM EDT Send to a Friend
Mylan (NASDAQ: MYL) is active today after AB-rated approval on generic Concerta (methylphenidate hydrochloride) per the FDA website 10/21.RBC analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login